trial

Tecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial

News Medical March 12, 2025 0Comment

NIH-sponsored trial data offer further evidence to help inform mpox treatment decisions.

Testing the Orbital Mechanics of Giant Mirrors

Earth Environment

The glasses case that saved Teddy Roosevelt’s life goes on display in North Dakota

In a Scientific First, Researchers Recovered Ancient DNA That Humans Left Behind on Rock Art and Cave Walls

Norwegian 4×4 Intervals Prove That Simple Is Not Easy